Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Clinical trial NCT00331409 · COMPLETED
Trial details
- NCT number
- NCT00331409
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2010-01-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.